• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

环氧乙烷接枝共聚物可降低脂质纳米颗粒的免疫原性。

Ethylene oxide graft copolymers reduce the immunogenicity of lipid nanoparticles.

作者信息

Qi Yalin, Han Hesong, Liu Albert, Zhao Sheng, Lawanprasert Atip, Nielsen Josefine Eilsø, Choudhary Hema, Liang Dengpan, Barron Annelise E, Murthy Niren

机构信息

Department of Bioengineering, University of California, Berkeley Berkeley California 94720 USA

Innovative Genomics Institute (IGI) Berkeley California 94704 USA.

出版信息

RSC Adv. 2024 Sep 20;14(41):30071-30076. doi: 10.1039/d4ra05007j. eCollection 2024 Sep 18.

DOI:10.1039/d4ra05007j
PMID:39309654
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11414743/
Abstract

Lipid nanoparticle (LNP)/mRNA complexes have great therapeutic potential but their PEG chains can induce the production of anti-PEG antibodies. New LNPs that do not contain PEG are greatly needed. We demonstrate here that poly-glutamic acid-ethylene oxide graft copolymers can replace the PEG on LNPs and outperform PEG-LNPs after chronic administration.

摘要

脂质纳米颗粒（LNP）/mRNA复合物具有巨大的治疗潜力，但其聚乙二醇（PEG）链可诱导抗PEG抗体的产生。因此，非常需要不含PEG的新型LNP。我们在此证明，聚谷氨酸-环氧乙烷接枝共聚物可以取代LNP上的PEG，并且在长期给药后其性能优于PEG-LNP。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2ca/11414743/311b497528be/d4ra05007j-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2ca/11414743/92404bb51c47/d4ra05007j-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2ca/11414743/8fdd1c2ea85a/d4ra05007j-s1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2ca/11414743/9e5aea66bf8b/d4ra05007j-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2ca/11414743/311b497528be/d4ra05007j-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2ca/11414743/92404bb51c47/d4ra05007j-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2ca/11414743/8fdd1c2ea85a/d4ra05007j-s1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2ca/11414743/9e5aea66bf8b/d4ra05007j-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2ca/11414743/311b497528be/d4ra05007j-f3.jpg

相似文献

1
Ethylene oxide graft copolymers reduce the immunogenicity of lipid nanoparticles.环氧乙烷接枝共聚物可降低脂质纳米颗粒的免疫原性。
RSC Adv. 2024 Sep 20;14(41):30071-30076. doi: 10.1039/d4ra05007j. eCollection 2024 Sep 18.
2
Tailored Monoacyl Poly(2-oxazoline)- and Poly(2-oxazine)-Lipids as PEG-Lipid Alternatives for Stabilization and Delivery of mRNA-Lipid Nanoparticles.定制单酰基聚（2-恶唑啉）和聚（2-恶嗪）脂质作为 PEG 脂质的替代品，用于稳定和递送 mRNA-脂质纳米颗粒。
Biomacromolecules. 2024 Jul 8;25(7):4591-4603. doi: 10.1021/acs.biomac.4c00651. Epub 2024 Jun 25.
3
Effect of Anti-PEG Antibody on Immune Response of mRNA-Loaded Lipid Nanoparticles.抗聚乙二醇抗体对 mRNA 负载脂质纳米颗粒免疫反应的影响。
Mol Pharm. 2024 Nov 4;21(11):5672-5680. doi: 10.1021/acs.molpharmaceut.4c00628. Epub 2024 Sep 26.
4
Diblock Copolymer Targeted Lipid Nanoparticles: Next-Generation Nucleic Acid Delivery System Produced by Confined Impinging Jet Mixers.两亲嵌段共聚物靶向脂质纳米颗粒：受限撞击射流混合器制备的新一代核酸给药系统。
ACS Appl Bio Mater. 2024 Nov 18;7(11):7595-7607. doi: 10.1021/acsabm.4c01176. Epub 2024 Oct 31.
5
Replacing poly(ethylene glycol) with RAFT lipopolymers in mRNA lipid nanoparticle systems for effective gene delivery.用 RAFT 脂聚合物代替聚乙二醇在 mRNA 脂质纳米粒系统中以实现有效的基因传递。
Int J Pharm. 2024 Nov 15;665:124695. doi: 10.1016/j.ijpharm.2024.124695. Epub 2024 Sep 15.
6
Substituting Poly(ethylene glycol) Lipids with Poly(2-ethyl-2-oxazoline) Lipids Improves Lipid Nanoparticle Repeat Dosing.用聚（2-乙基-2-恶唑啉）脂质替代聚乙二醇脂质可改善脂质纳米粒的重复给药。
Adv Healthc Mater. 2024 Jul;13(17):e2304033. doi: 10.1002/adhm.202304033. Epub 2024 Mar 10.
7
PEG shedding-rate-dependent blood clearance of PEGylated lipid nanoparticles in mice: Faster PEG shedding attenuates anti-PEG IgM production.聚乙二醇（PEG）化脂质纳米颗粒在小鼠体内的血清除率依赖于 PEG 脱落率：PEG 脱落越快，抗-PEG IgM 产生越少。
Int J Pharm. 2020 Oct 15;588:119792. doi: 10.1016/j.ijpharm.2020.119792. Epub 2020 Aug 19.
8
Analysis of PEG-lipid anchor length on lipid nanoparticle pharmacokinetics and activity in a mouse model of traumatic brain injury.聚乙二醇化脂质锚长度对创伤性脑损伤小鼠模型中脂质纳米颗粒药代动力学和活性的分析。
Biomater Sci. 2023 Jun 13;11(12):4238-4253. doi: 10.1039/d2bm01846b.
9
Engineering LNPs with polysarcosine lipids for mRNA delivery.用聚肌氨酸脂质工程化脂质纳米颗粒用于mRNA递送。
Bioact Mater. 2024 Mar 16;37:86-93. doi: 10.1016/j.bioactmat.2024.03.017. eCollection 2024 Jul.
10
Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine.SARS-CoV-2脂质纳米颗粒mRNA疫苗可增强人体中的抗聚乙二醇抗体。
ACS Nano. 2022 Aug 23;16(8):11769-11780. doi: 10.1021/acsnano.2c04543. Epub 2022 Jun 27.

引用本文的文献

1
Circular RNAs as Targets for Developing Anticancer Therapeutics.环状RNA作为开发抗癌疗法的靶点
Cells. 2025 Jul 18;14(14):1106. doi: 10.3390/cells14141106.
2
Regulating Immune Responses Induced by PEGylated Messenger RNA-Lipid Nanoparticle Vaccine.调控聚乙二醇化信使核糖核酸-脂质纳米颗粒疫苗诱导的免疫反应
Vaccines (Basel). 2024 Dec 27;13(1):14. doi: 10.3390/vaccines13010014.

本文引用的文献

1
Engineering LNPs with polysarcosine lipids for mRNA delivery.用聚肌氨酸脂质工程化脂质纳米颗粒用于mRNA递送。
Bioact Mater. 2024 Mar 16;37:86-93. doi: 10.1016/j.bioactmat.2024.03.017. eCollection 2024 Jul.
2
Substituting Poly(ethylene glycol) Lipids with Poly(2-ethyl-2-oxazoline) Lipids Improves Lipid Nanoparticle Repeat Dosing.用聚（2-乙基-2-恶唑啉）脂质替代聚乙二醇脂质可改善脂质纳米粒的重复给药。
Adv Healthc Mater. 2024 Jul;13(17):e2304033. doi: 10.1002/adhm.202304033. Epub 2024 Mar 10.
3
Zwitterionic Polymer-Decorated Lipid Nanoparticles for mRNA Delivery in Mammalian Cells.
两性离子聚合物修饰的脂质纳米颗粒用于哺乳动物细胞中的 mRNA 递送。
Biomacromolecules. 2023 Dec 11;24(12):5654-5665. doi: 10.1021/acs.biomac.3c00649. Epub 2023 Nov 13.
4
On the origin of the low immunogenicity and biosafety of a neutral α-helical polypeptide as an alternative to polyethylene glycol.关于一种中性α-螺旋多肽作为聚乙二醇替代品的低免疫原性和生物安全性的起源
Bioact Mater. 2023 Oct 21;32:333-343. doi: 10.1016/j.bioactmat.2023.10.011. eCollection 2024 Feb.
5
Anti-PEG antibodies enriched in the protein corona of PEGylated nanocarriers impact the cell uptake.聚乙二醇化纳米载体蛋白冠中富集的抗聚乙二醇抗体影响细胞摄取。
Nanoscale Horiz. 2023 Sep 26;8(10):1377-1385. doi: 10.1039/d3nh00198a.
6
mRNA-based cancer therapeutics.mRNA 癌症疗法。
Nat Rev Cancer. 2023 Aug;23(8):526-543. doi: 10.1038/s41568-023-00586-2. Epub 2023 Jun 13.
7
Studying how administration route and dose regulates antibody generation against LNPs for mRNA delivery with single-particle resolution.以单颗粒分辨率研究给药途径和剂量如何调节针对用于mRNA递送的脂质纳米颗粒的抗体产生。
Mol Ther Methods Clin Dev. 2023 May 11;29:450-459. doi: 10.1016/j.omtm.2023.05.008. eCollection 2023 Jun 8.
8
PEGylated Lipid Nanoparticle Formulations: Immunological Safety and Efficiency Perspective.聚乙二醇化脂质纳米颗粒制剂：免疫安全性和效率视角。
Bioconjug Chem. 2023 Jun 21;34(6):941-960. doi: 10.1021/acs.bioconjchem.3c00174. Epub 2023 May 10.
9
Impact of anti-PEG antibodies induced by SARS-CoV-2 mRNA vaccines.由 SARS-CoV-2 mRNA 疫苗引起的抗聚乙二醇抗体的影响。
Nat Rev Immunol. 2023 Mar;23(3):135-136. doi: 10.1038/s41577-022-00825-x.
10
Discrete Libraries of Amphiphilic Poly(ethylene glycol) Graft Copolymers: Synthesis, Assembly, and Bioactivity.两亲性聚乙二醇接枝共聚物的离散文库：合成、组装和生物活性。
J Am Chem Soc. 2022 Oct 26;144(42):19466-19474. doi: 10.1021/jacs.2c07859. Epub 2022 Oct 14.